Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world outcomes associated with switching to anti-TNFs versus other biologics in Crohn's Disease patients: A retrospective analysis using German claims data.
Zhuleku E, Antolin-Fontes B, Borsi A, Nissinen R, Bravatà I, Barthelmes JN, Le Bars M, Lee J, Passey A, Maywald U, Deiters B, Bokemeyer B, Wilke T, Ghiani M. Zhuleku E, et al. Among authors: borsi a. Therap Adv Gastroenterol. 2022 Nov 4;15:17562848221130554. doi: 10.1177/17562848221130554. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 36353736 Free PMC article.
A nationwide real-world study on dynamic ustekinumab dosing and concomitant medication use among Crohn's disease patients in Finland.
Sipponen T, Af Björkesten CG, Hallinen T, Ilus T, Soini E, Eberl A, Heikura M, Kellokumpu M, Koskela R, Nielsen C, Nuutinen H, Heikkinen M, Suhonen UM, Tillonen J, Wennerström ECM, Borsi A, Koivunen MR; FINUSTE Study group. Sipponen T, et al. Among authors: borsi a. Scand J Gastroenterol. 2021 Jun;56(6):661-670. doi: 10.1080/00365521.2021.1906315. Epub 2021 Apr 5. Scand J Gastroenterol. 2021. PMID: 33820465 Free article.
Increased use of biologics in the era of TNF-α inhibitors did not reduce surgical rate but prolonged the time from diagnosis to first time intestinal resection among patients with Crohn's disease and ulcerative colitis - a Danish register-based study from 2003-2016.
Qvist N, Vadstrup K, Alulis S, Borsi A, Munkholm P, Olsen J. Qvist N, et al. Among authors: borsi a. Scand J Gastroenterol. 2021 May;56(5):537-544. doi: 10.1080/00365521.2021.1897670. Epub 2021 Mar 18. Scand J Gastroenterol. 2021. PMID: 33736551
Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn's disease cohort.
Af Björkesten CG, Ilus T, Hallinen T, Soini E, Eberl A, Hakala K, Heikura M, Jussila A, Koskela R, Koskinen I, Moilanen V, Nielsen C, Nieminen U, Nuutinen H, Heikkinen M, Suhonen UM, Tillonen J, Utriainen K, Vihriälä I, Wennerström C, Borsi A, Nissinen R, Koivunen MR, Sipponen T. Af Björkesten CG, et al. Among authors: borsi a. Eur J Gastroenterol Hepatol. 2020 Dec;32(12):1507-1513. doi: 10.1097/MEG.0000000000001831. Eur J Gastroenterol Hepatol. 2020. PMID: 32868649 Free PMC article.
22 results